Nanoxel

Fresenius Kabi Oncology Limited🇵🇭 Food and Drug Administration - Philippines

Approval Id: 59a97a97f45bafb6
Drug Approval Philippines Name: Nanoxel
Product Name: Nanoxel
Registration Number: DR-XY42006
Brand Name: Nanoxel
Generic Name: Paclitaxel
Dosage Form: Solution For Nanoparticle Injection For Infusion (IV)
Dosage Strength: Formulation: One vial of Paclitaxel solution for Nanoparticle Injection for Infusion (IV) Each mL contains: Paclitaxel-20 mg One vial of Concentrate Excipients for Paclitaxel Solution for Nanoparticle Injection Each mL contains: Polymer PNP-10mg Sodium deoxycholate-6.67 mg Sodium citrate-10mg
Manufacturer: Fresenius Kabi Oncology Limited
Importer: Fresenius Kabi Philippines, Inc.
Distributor: Fresenius Kabi Philippines, Inc.
Company Detail Path: /organization/fresenius-kabi-oncology-limited
Issuance Date: 25 May 2021
Expiry Date: 06 May 2026
Classification: Prescription Drug (RX)

Approved

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

59a97a97f45bafb6

Type

Standard